YU32396A - Novi polimorfi lisopitron dihidrohlorida i njegovi hidrantni oblici, postupci za izradu i sastavi koji ga sadrže - Google Patents
Novi polimorfi lisopitron dihidrohlorida i njegovi hidrantni oblici, postupci za izradu i sastavi koji ga sadržeInfo
- Publication number
- YU32396A YU32396A YU32396A YU32396A YU32396A YU 32396 A YU32396 A YU 32396A YU 32396 A YU32396 A YU 32396A YU 32396 A YU32396 A YU 32396A YU 32396 A YU32396 A YU 32396A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- dihydrochloride
- lysopitron
- preparation process
- compositions containing
- hydrated forms
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- RGDLQJUAYQRGBC-UHFFFAOYSA-N 2-[4-[4-(4-chloropyrazol-1-yl)butyl]piperazin-1-yl]pyrimidine;dihydrochloride Chemical compound Cl.Cl.C1=C(Cl)C=NN1CCCCN1CCN(C=2N=CC=CN=2)CC1 RGDLQJUAYQRGBC-UHFFFAOYSA-N 0.000 abstract 2
- 238000002441 X-ray diffraction Methods 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000002329 infrared spectrum Methods 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES09501086A ES2099031B1 (es) | 1995-05-31 | 1995-05-31 | Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU32396A true YU32396A (sh) | 1999-07-28 |
Family
ID=8290585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU32396A YU32396A (sh) | 1995-05-31 | 1996-05-30 | Novi polimorfi lisopitron dihidrohlorida i njegovi hidrantni oblici, postupci za izradu i sastavi koji ga sadrže |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5872125A (env) |
| EP (1) | EP0771798A1 (env) |
| JP (1) | JPH10503532A (env) |
| CN (1) | CN1076020C (env) |
| AR (1) | AR003952A1 (env) |
| AU (1) | AU699210B2 (env) |
| BG (1) | BG62966B1 (env) |
| CA (1) | CA2196425A1 (env) |
| CO (1) | CO4700461A1 (env) |
| CZ (1) | CZ24797A3 (env) |
| EE (1) | EE9700067A (env) |
| ES (1) | ES2099031B1 (env) |
| GE (1) | GEP20002241B (env) |
| HU (1) | HUP9700284A3 (env) |
| IL (1) | IL118494A0 (env) |
| IN (1) | IN186820B (env) |
| IS (1) | IS4420A (env) |
| MA (1) | MA23883A1 (env) |
| MX (1) | MX9700792A (env) |
| NO (1) | NO310073B1 (env) |
| NZ (1) | NZ308110A (env) |
| PL (1) | PL318280A1 (env) |
| RU (1) | RU2178789C2 (env) |
| SK (1) | SK12697A3 (env) |
| TR (1) | TR199600455A2 (env) |
| UY (1) | UY24241A1 (env) |
| WO (1) | WO1996038439A1 (env) |
| YU (1) | YU32396A (env) |
| ZA (1) | ZA964139B (env) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6869970B2 (en) | 2002-02-04 | 2005-03-22 | Novartis Ag | Crystalline salt forms of valsartan |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU206109B (en) * | 1987-10-26 | 1992-08-28 | Pfizer | Process for producing heterocyclic carbonylpropyl pyrimidinyl piperazine derivatives and pharmaceutical compositions comprising same |
| FR2642759B1 (fr) * | 1989-02-09 | 1991-05-17 | Laboratorios Esteve Sa | Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante |
| FR2654621B1 (fr) * | 1989-11-22 | 1994-09-23 | Esteve Labor Dr | Inhibition du syndrome d'abstinence. |
| FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
| FR2671972B1 (fr) * | 1991-01-25 | 1995-03-03 | Esteve Labor Dr | Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives. |
| JP3001281B2 (ja) * | 1991-03-06 | 2000-01-24 | 日本碍子株式会社 | ハニカムモノリスヒータ |
| FR2673628B1 (fr) * | 1991-03-07 | 1993-07-09 | Esteve Labor Dr | Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles. |
| FR2705098B1 (fr) * | 1993-05-10 | 1995-08-04 | Esteve Labor Dr | Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) . |
-
1995
- 1995-05-31 ES ES09501086A patent/ES2099031B1/es not_active Expired - Fee Related
-
1996
- 1996-05-21 AR ARP960102643A patent/AR003952A1/es unknown
- 1996-05-21 IN IN921CA1996 patent/IN186820B/en unknown
- 1996-05-23 ZA ZA9604139A patent/ZA964139B/xx unknown
- 1996-05-29 EE EE9700067A patent/EE9700067A/xx unknown
- 1996-05-29 CA CA002196425A patent/CA2196425A1/en not_active Abandoned
- 1996-05-29 CN CN96190703A patent/CN1076020C/zh not_active Expired - Fee Related
- 1996-05-29 JP JP8536224A patent/JPH10503532A/ja active Pending
- 1996-05-29 RU RU97102703/04A patent/RU2178789C2/ru active
- 1996-05-29 US US08/776,113 patent/US5872125A/en not_active Expired - Fee Related
- 1996-05-29 NZ NZ308110A patent/NZ308110A/xx unknown
- 1996-05-29 SK SK126-97A patent/SK12697A3/sk unknown
- 1996-05-29 WO PCT/ES1996/000121 patent/WO1996038439A1/es not_active Ceased
- 1996-05-29 HU HU9700284A patent/HUP9700284A3/hu unknown
- 1996-05-29 EP EP96914220A patent/EP0771798A1/en not_active Withdrawn
- 1996-05-29 MX MX9700792A patent/MX9700792A/es unknown
- 1996-05-29 CZ CZ97247A patent/CZ24797A3/cs unknown
- 1996-05-29 MA MA24252A patent/MA23883A1/fr unknown
- 1996-05-29 AU AU57650/96A patent/AU699210B2/en not_active Ceased
- 1996-05-29 GE GEAP19963558A patent/GEP20002241B/en unknown
- 1996-05-29 PL PL96318280A patent/PL318280A1/xx unknown
- 1996-05-30 IL IL11849496A patent/IL118494A0/xx unknown
- 1996-05-30 CO CO96027954A patent/CO4700461A1/es unknown
- 1996-05-30 UY UY24241A patent/UY24241A1/es not_active IP Right Cessation
- 1996-05-30 YU YU32396A patent/YU32396A/sh unknown
- 1996-05-31 TR TR96/00455A patent/TR199600455A2/xx unknown
-
1997
- 1997-01-27 BG BG101176A patent/BG62966B1/bg unknown
- 1997-01-29 IS IS4420A patent/IS4420A/is unknown
- 1997-01-29 NO NO970392A patent/NO310073B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200505428A (en) | Immunosuppressant compounds and compositions | |
| SI1638551T1 (sl) | Imunosupresivne spojine in sestavki | |
| ATE299710T1 (de) | Methoden zur behandlung von muskelerkrankungen und muskelstörungen | |
| ES2126122T3 (es) | Nitrato-aminoacido-disulfuros para la terapia de enfermedades del sistema cardio-circulatorio. | |
| RU94046067A (ru) | Замещенные 1,2,3,4-тетрагидроизохинолины, промежуточные продукты, фармкомпозиция и способ лечения | |
| PT78751B (en) | Preparation process of 2-pyrimidinyl-1-piperazine derivatives and medicines containing them | |
| ES2142570T3 (es) | Bisesteres de acido alqu(en)ildicarboxilico, su empleo, asi como procedimientos para su obtencion. | |
| DE69426033D1 (de) | Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna | |
| ATE182333T1 (de) | Heterocyclische verbindungen, ihre herstellung und verwendung | |
| HUT61022A (en) | Process for producing 8-substituted purine derivatives functioning as selective adenosine receptor, as well as pharmaceutical compositions comprising same as active ingredient | |
| IL98647A0 (en) | Anti-inflammatory factor,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| PL346143A1 (en) | Tan-1057 derivatives | |
| YU13392A (sh) | ANTITELA NA HUMANI RECEPTOR ZA IgE | |
| PT677051E (pt) | Derivados de benzoil-ecgonina ecgonina e ecgonidina como medicamentos | |
| ZA929855B (en) | Pyrrolidine compounds process for preparing them and pharmaceutical compositions containing them | |
| IL143382A0 (en) | Human adult astrocytes, their preparation and uses thereof | |
| BG101176A (en) | Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them | |
| SE9504618D0 (sv) | New Compounds | |
| YU57695A (sh) | (r)-enantiomer derivata dihidro-2,3-benzodiazepina | |
| RU94038063A (ru) | 3-фенилуреидо-азепин-2-оны и -бензазепин-2-оны, способы их получения, промежуточные соединения, фармацевтические композиции и способы лечения | |
| IL59295A0 (en) | Dehydropeptide compounds,their production and pharmaceutical compositions containing them | |
| BR9206276A (pt) | Processo aperfeiçoado para a manufatura de um pó capaz de ser reconstituído como uma bebida de suco por meio da adição de água no mesmo, e, processo para a preparação de um concentrado de suco. | |
| HUT39449A (en) | Process for producing new benzazepine derivatives and pharmaceutical compositions containing them | |
| DE50006244D1 (en) | Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine | |
| GR3032531T3 (en) | Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases |